Canada markets close in 3 hours 13 minutes

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.7700+0.1700 (+6.54%)
As of 11:10AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 13.63M
Enterprise Value 11.30M
Trailing P/E 4.84
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.24
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 17.93

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3103.12%
S&P500 52-Week Change 328.04%
52 Week High 34.9900
52 Week Low 30.7500
50-Day Moving Average 32.4444
200-Day Moving Average 31.3083

Share Statistics

Avg Vol (3 month) 3764.11k
Avg Vol (10 day) 315.14k
Shares Outstanding 55.45M
Implied Shares Outstanding 65.45M
Float 8413.26M
% Held by Insiders 10.00%
% Held by Institutions 14.68%
Shares Short (Apr 30, 2024) 422.44k
Short Ratio (Apr 30, 2024) 40.24
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.41%
Shares Short (prior month Mar 28, 2024) 4437.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 10, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Feb 10, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.46%
Return on Equity (ttm)-57.31%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -764k
Net Income Avi to Common (ttm)-1.78M
Diluted EPS (ttm)-0.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.01M
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.93
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-707k
Levered Free Cash Flow (ttm)-436.62k